A facility reported that during use of the duraseal spine ous 3ml kit 5kit/box ce approved (204003), the staff nurse noted that after injecting the syringe (blue) to vial, the solution in the vial solidified and could not retrieve.The product was in contact with patient.There was no patient injury noted and no delay in surgery has been reported.
|
Duraseal (204003) was not returned for evaluation after three good faith attempts (gfes) were made.Lot number information has been provided; therefore, device history record (dhr) was reviewed, and no anomalies were found.Per the fmea, potential causes of failure include: performance, application - gel delivery, performance, solution mixing and coverage.The risk remains acceptable per the risk analysis.If additional relevant information becomes available in the future, this complaint will be reopened, and the respective evaluation performed.Trends will be monitored for this and similar issues.At present, we consider this complaint to be closed.
|